Collectively, these findings and those presented previously [27] demonstrate that the anticancer activities associated with CST-Abl expression are mediated in part via the induction of MET programs, which alleviate the cancer-initiating properties of TNBCs. This evidence concerns the gene ABL1 and cancer.